Table 2.
PLB Week 0 |
PLB Week 16 |
p value Δ Week 0 vs 16 |
PIO Week 0 |
PIO Week 16 |
p value Δ Week 0 vs 16 |
Δ PLB vs PIO |
p value Δ PLB vs PIO |
|
---|---|---|---|---|---|---|---|---|
scABD (%) | 7.1 ± 0.8 | 6.8 ± 1.1 | 0.84 | 7.6 ± 0.8 | 9.3 ± 1.1 | 0.23 | 2.0 ± 2.1 | 0.32 |
scFEM (%) | 9.9 ± 0.9 | 8.7 ± 0.8 | 0.30 | 8.5 ± 0.9 | 10.6 ± 0.9 | 0.07 | 3.3 ± 1.6 | 0.04 |
Values are presented as mean ± SEM
PIO, pioglitazone group; PLB, placebo group